A male preponderance in patients with Indian post kala‐azar dermal leishmaniasis is associated with increased circulating levels of testosterone

Post kala‐azar dermal leishmaniasis (PKDL) is a neglected parasitic disease that occurs after apparent cure from visceral leishmaniasis (VL) and poses a challenge for elimination of VL, being its proposed reservoir. Several epidemiological studies have proposed that sex hormones may account for the increased susceptibility of males towards infectious diseases, including leishmaniasis; however, the role of testosterone and sex bias, if any, in PKDL has not been evaluated.

[1]  M. Ramam,et al.  Histopathological characteristics of post kala-azar dermal leishmaniasis: a series of 88 patients. , 2015, Indian journal of dermatology, venereology and leprology.

[2]  B. Arana,et al.  Research priorities for elimination of visceral leishmaniasis. , 2014, The Lancet. Global health.

[3]  N. Santarém,et al.  Deception and Manipulation: The Arms of Leishmania, a Successful Parasite , 2014, Front. Immunol..

[4]  Hannah Bernin,et al.  Sex bias in the outcome of human tropical infectious diseases: influence of steroid hormones. , 2014, The Journal of infectious diseases.

[5]  E. Fish,et al.  SeXX matters in immunity. , 2014, Trends in immunology.

[6]  R. Haque,et al.  Clinical and immunological aspects of post-kala-azar dermal leishmaniasis in Bangladesh. , 2013, The American journal of tropical medicine and hygiene.

[7]  M. Nykter,et al.  Transcriptional Analysis Reveals Gender-Specific Changes in the Aging of the Human Immune System , 2013, PloS one.

[8]  F. Abad‐Franch,et al.  Sex Bias in Infectious Disease Epidemiology: Patterns and Processes , 2013, PloS one.

[9]  D. Mukhopadhyay,et al.  Evaluation of serological markers to monitor the disease status of Indian post kala-azar dermal leishmaniasis. , 2012, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[10]  S. Sundar,et al.  Post‐kala‐azar dermal leishmaniasis in visceral leishmaniasis‐endemic communities in Bihar, India , 2012, Tropical medicine & international health : TM & IH.

[11]  A. Ranjan,et al.  Clinical epidemiologic profile of a cohort of post-kala-azar dermal leishmaniasis patients in Bihar, India. , 2012, The American journal of tropical medicine and hygiene.

[12]  D. Mukhopadhyay,et al.  Targets for immunochemotherapy in leishmaniasis , 2012, Expert review of anti-infective therapy.

[13]  S. Sundar,et al.  Post-kala-azar dermal leishmaniasis (PKDL) in visceral leishmaniasis-endemic communities in Bihar, India. , 2012, Tropical medicine & international health : TM & IH.

[14]  S. Rijal,et al.  Post-Kala-azar Dermal Leishmaniasis in Nepal: A Retrospective Cohort Study (2000–2010) , 2011, PLoS neglected tropical diseases.

[15]  S. Roy,et al.  Miltefosine effectively modulates the cytokine milieu in Indian post kala-azar dermal leishmaniasis. , 2011, The Journal of infectious diseases.

[16]  S. Roy,et al.  Case Report: Case Series of Misdiagnosis with rK39 Strip Test in Indian Leishmaniasis , 2011 .

[17]  N. Bagherani,et al.  Vitiligo: A review of the published work , 2011, The Journal of dermatology.

[18]  Nathalia Dias Negrão Murback,et al.  Leishmaniose tegumentar americana: estudo clínico, epidemiológico e laboratorial realizado no Hospital Universitário de Campo Grande, Mato Grosso do Sul, Brasil , 2011 .

[19]  N. D. N. Murback,et al.  American cutaneous leishmaniasis: clinical, epidemiological and laboratory studies conducted at a university teaching hospital in Campo Grande, Mato Grosso do Sul, Brazil. , 2011, Anais brasileiros de dermatologia.

[20]  M. Chatterjee,et al.  Post‐kala‐azar dermal leishmaniasis – an overview , 2010, International journal of dermatology.

[21]  A. Satoskar,et al.  Sex Hormones and Modulation of Immunity against Leishmaniasis , 2009, Neuroimmunomodulation.

[22]  E. Fish The X-files in immunity: sex-based differences predispose immune responses , 2008, Nature Reviews Immunology.

[23]  M. Chatterjee,et al.  Increased levels of interleukin-10 and IgG3 are hallmarks of Indian post-kala-azar dermal leishmaniasis. , 2008, The Journal of infectious diseases.

[24]  A. Satoskar,et al.  17β-ESTRADIOL INCREASES LEISHMANIA MEXICANA KILLING IN MACROPHAGES FROM DBA/2 MICE BY ENHANCING PRODUCTION OF NITRIC OXIDE BUT NOT PRO-INFLAMMATORY CYTOKINES , 2007 .

[25]  A. Satoskar,et al.  17Beta-estradiol increases Leishmania mexicana killing in macrophages from DBA/2 mice by enhancing production of nitric oxide but not pro-inflammatory cytokines. , 2007, The American journal of tropical medicine and hygiene.

[26]  S. Klein,et al.  Hormonal and immunological mechanisms mediating sex differences in parasite infection , 2004, Parasite immunology.

[27]  E. Khalil,et al.  The natural history of Sudanese post-kala-azar dermal leishmaniasis: clinical, immunological and prognostic features. , 2002, Annals of Tropical Medicine and Parasitology.

[28]  B. Chandrasekar,et al.  Gender Is a Major Determinant of the Clinical Evolution and Immune Response in Hamsters Infected with Leishmania spp , 2002, Infection and Immunity.

[29]  A. Nandy,et al.  Ten years of kala-azar in west Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas? , 1992, Bulletin of the World Health Organization.

[30]  D. D. Munro,et al.  POST KALA‐AZAR DERMAL LEISHMANIASIS , 1972, The British journal of dermatology.